← Oncology Approval Tracker

FDA DECISION ·

Trametinib tablets (first generic)

trametinib · Novugen Oncology

First generic approvalFirst genericBRAF-mutated solid tumors
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic of the referenced trametinib tablets. FDA’s first-generics list identifies BRAF V600-defined melanoma, lung cancer, anaplastic thyroid cancer, selected other solid tumors and pediatric low-grade glioma. The applicable indication and combination are product- and formulation-specific.

LAMPGEN ANALYSIS

Why it matters

This approval concerns the tablet presentation of an established MEK inhibitor.

What research teams should watch

Verify the marketed generic’s label, BRAF variant and partner regimen; check for differences between tablets and oral solution.

PRIMARY RECORDS

Sources